The CEO's Balancing Act

By Fintan Walton

Pharma Deals Review: Vol 2007 Issue 88 (Table of Contents)

Published: 1 Oct-2007

DOI: 10.3833/pdr.v2007.i88.284     ISSN: 1756-7874

Section: Business Commentaries



A good CEO in biotech, like all CEOs, has to have the ability to build cash reserves to enable the company to grow and provide a return to investors. The problem for most biotechs, however, is that they do not even generate revenues, never mind generate profits. A good biotech CEO then, as a primary skill, has to have the ability to raise significant amounts of cash through successive rounds of equity financing, and, if available, debit financing. His or her second skill is then to transform that investment through value creation, that is, through good research and development of products and technologies.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details